(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.02%) $0.926
(-0.05%) $10.84
(-0.13%) $0.791
(-0.09%) $92.49
Live Chart Being Loaded With Signals
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases...
Stats | |
---|---|
Today's Volume | 9.12M |
Average Volume | 2.84M |
Market Cap | 2.38B |
EPS | $0 ( 2024-03-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.43 |
ATR14 | $0.594 (2.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-04-27 | Sessa Capital (master), L.p. | Sell | 15 567 497 | Common Stock |
2023-04-27 | Wysenski Nancy | Sell | 128 981 | Option to Purchase Common Stock |
2023-04-27 | Wysenski Nancy | Sell | 22 200 | Option to Purchase Common Stock |
2023-04-27 | Wysenski Nancy | Sell | 23 000 | Option to Purchase Common Stock |
2023-04-27 | Wysenski Nancy | Sell | 33 000 | Option to Purchase Common Stock |
INSIDER POWER |
---|
-62.68 |
Last 100 transactions |
Buy: 11 373 023 | Sell: 48 540 195 |
Volume Correlation
Provention Bio Inc Correlation
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Provention Bio Inc Correlation - Currency/Commodity
Provention Bio Inc Financials
Annual | 2022 |
Revenue: | $12.90M |
Gross Profit: | $12.38M (96.03 %) |
EPS: | $-1.520 |
Q4 | 2022 |
Revenue: | $10.81M |
Gross Profit: | $10.30M (95.26 %) |
EPS: | $-0.450 |
Q3 | 2022 |
Revenue: | $756 000 |
Gross Profit: | $756 000 (100.00 %) |
EPS: | $-0.340 |
Q2 | 2022 |
Revenue: | $746 000 |
Gross Profit: | $746 000 (100.00 %) |
EPS: | $-0.460 |
Financial Reports:
No articles found.
Provention Bio Inc
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China. Provention Bio, Inc. was incorporated in 2016 and is headquartered in Red Bank, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators